Search

Objective: To investigate the antibacterial activity of cinnamon oil alone and in combination with a multipurpose contact lens disinfectant solution (MPS) as well as tobramycin against multi drμg resistant conjunctival bacteria both in planktonic and sessile forms.Methods: Minimum inhibitory concentrations (MIC) of tobramycin and cinnamon oil against 19 bacterial strains were investigated against planktonic and sessile cells by micro-dilution methods. Synergistic effects were determined by well diffusion and micro-dilution tissue culture plate methods for planktonic and sessile cells respectively. Time kill assay was performed to study the bactericidal effect of cinnamon oil in concentrations ranging from 5% to 0.312% combined with an MPS with respect to time.Results: MICs of cinnamon oil against planktonic bacteria ranged from 0.04% to 1.25% versus 0.156% to 5% for sessile cells. Combination of cinnamon oil with tobramycin had a synergistic effect against most tested organisms. The MIC values of cinnamon oil in combination with tobramycin was significantly lower than cinnamon oil alone against biofilm production (P=0.004). Time kill assay revealed that combination of cinnamon oil and disinfectant successfully eradicated the tested microorganisms at all tested concentrations within 2h contact time except for 0.312% concentration (3h) versus 24h for MPS alone.Conclusion: Cinnamon oil has a promising antimicrobial effect. It could be a probable candidate for contact lens disinfection. [ABSTRACT FROM AUTHOR]

• Herbal oils are promising sources of antimicrobial agents. • This is the first time to investigate the antimicrobial activities of fennel essential oil against biofilm formed by Candida species causing vulvovaginal candidiasis. • This is the first study that investigates the combined antimicrobial effect of fluconazole and fennel oil against Candida species. To screen the antimicrobial activities of some plant essential oils against clinical isolates of C. albicans causing vulvovaginal candidiasis (VVC) and to investigate the antifungal effect of the most active one against planktonic and sessile cells compared to fluconazole. Screening of biofilm production by C. albicans causing VVC was performed by tissue culture plate method. The antifungal susceptibility of fluconazole was performed by disk diffusion method. Antifungal activities of nine essential oils were screened against strong biofilm-producer, fluconazole-resistant or dose-dependently susceptible clinical isolates and Candida albicans ATCC 10,231 by well diffusion method. Determination of the minimum inhibitory concentration (MIC) of fennel essential oil and fluconazole against planktonic and sessile cells were performed by microdilution methods. Determination of the combined antimicrobial activity of fennel oil and fluconazole was evaluated by checkerboard microdilution assay. From 19 C. albicans strains, 10/19 showed strong ability to form biofilms. None of the tested clinical isolates was sensitive to fluconazole. Fennel oil had significantly higher antifungal activities against tested C. albicans compared with other tested oils (P = 0.000). The MICs of fennel oil for planktonic cells ranged from 0.78% to 6.25% with MIC50 of 3.12% and MIC90 of 6.25%, while concentrations ranging between 6.25% and 25% resulted in 50% biofilm reduction. Synergy or addition between fennel oil and fluconazole were detected against 7/11 strains, while no antagonism was detected. Fennel oil alone or in combination with fluconazole could provide a promising approach to the management of VVC caused by drug-resistant strains. [ABSTRACT FROM AUTHOR]

Abstract: Objective: A proliferation-inducing ligand (APRIL) is a new member of the tumour necrosis factor family which is intimately connected to the regulation of cellular pathways. The aim of this study was to assess serum concentrations of APRIL in systemic sclerosis patients, and to correlate them with the main clinical and serological features of the disease. Methods: Sera from 35 patients with systemic sclerosis, 25 had limited cutaneous and 10 had diffuse cutaneous subtypes, and 35 normal healthy subjects were assayed for APRIL by Enzyme Linked Immunosorbant Assay. Demographic, clinical, autoantibodies and serological data were prospectively assessed. Results: Serum APRIL concentrations were higher in patients with systemic sclerosis and in both its subtypes compared to the healthy controls (p <0.0001 in all). Patients with elevated APRIL levels had significantly higher incidences of myositis than those with normal levels (p =0.04). We did not find significant differences in other organ involvement prevalence between systemic sclerosis patients with elevated vs. normal APRIL levels. In addition, the frequencies of autoantibodies (i.e., anti-topoisomerase I, anti-centromere) were comparable between both groups. Serum APRIL levels were correlated with serum γ-globulins concentrations (r =0.404, p =0.016) but not with C-reactive protein, skin score, nor pulmonary functions. Serum APRIL was also correlated with creatine kinase levels only in systemic sclerosis patients with myositis (r =0.786, p =0.02). Conclusion: Our preliminary results suggest increased serum APRIL levels in systemic sclerosis patients, particularly in those associated with myositis and hypergammaglobinemia. To confirm our results, we propose that larger scale, multicentre studies with longer evaluation periods are needed. [ABSTRACT FROM AUTHOR]